Respiratory Support of Infants With Congenital Diaphragmatic Hernia

Optimisation of respiratory support of infants with congenital diaphragmatic hernia (CDH) is critical. Infants with CDH often have severe lung hypoplasia and abnormal development of their pulmonary vasculature, leading to ventilation perfusion mismatch. It is vital that lung protective ventilation s...

Full description

Bibliographic Details
Main Authors: Emma Williams, Anne Greenough
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-12-01
Series:Frontiers in Pediatrics
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fped.2021.808317/full
_version_ 1831758234301497344
author Emma Williams
Anne Greenough
Anne Greenough
Anne Greenough
author_facet Emma Williams
Anne Greenough
Anne Greenough
Anne Greenough
author_sort Emma Williams
collection DOAJ
description Optimisation of respiratory support of infants with congenital diaphragmatic hernia (CDH) is critical. Infants with CDH often have severe lung hypoplasia and abnormal development of their pulmonary vasculature, leading to ventilation perfusion mismatch. It is vital that lung protective ventilation strategies are employed during both initial stabilisation and post-surgical repair to avoid ventilator induced lung damage and oxygen toxicity to prevent further impairment to an already diminished gas-exchanging environment. There is a lack of robust evidence for the routine use of surfactant therapy during initial resuscitation of infants with CDH and thus administration cannot be recommended outside clinical trials. Additionally, inhaled nitric oxide has been shown to have no benefit in reducing the mortality rates of infants with CDH. Other therapeutic agents which beneficially act on pulmonary hypertension are currently being assessed in infants with CDH in randomised multicentre trials. The role of novel ventilatory modalities such as closed loop automated oxygen control, liquid ventilation and heliox therapy may offer promise for infants with CDH, but the benefits need to be determined in appropriately designed clinical trials.
first_indexed 2024-12-22T00:45:02Z
format Article
id doaj.art-b590942df25745b097821f32dfadbc34
institution Directory Open Access Journal
issn 2296-2360
language English
last_indexed 2024-12-22T00:45:02Z
publishDate 2021-12-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Pediatrics
spelling doaj.art-b590942df25745b097821f32dfadbc342022-12-21T18:44:34ZengFrontiers Media S.A.Frontiers in Pediatrics2296-23602021-12-01910.3389/fped.2021.808317808317Respiratory Support of Infants With Congenital Diaphragmatic HerniaEmma Williams0Anne Greenough1Anne Greenough2Anne Greenough3Department of Women and Children's Health, School of Life Course Sciences, Faculty of Life Sciences and Medicine, King's College London, London, United KingdomDepartment of Women and Children's Health, School of Life Course Sciences, Faculty of Life Sciences and Medicine, King's College London, London, United KingdomAsthma UK Centre for Allergic Mechanisms in Asthma, King's College London, London, United KingdomNational Institute for Health Research (NIHR) Biomedical Research Centre at Guy's and St Thomas' National Health Service (NHS) Foundation Trust and King's College London, London, United KingdomOptimisation of respiratory support of infants with congenital diaphragmatic hernia (CDH) is critical. Infants with CDH often have severe lung hypoplasia and abnormal development of their pulmonary vasculature, leading to ventilation perfusion mismatch. It is vital that lung protective ventilation strategies are employed during both initial stabilisation and post-surgical repair to avoid ventilator induced lung damage and oxygen toxicity to prevent further impairment to an already diminished gas-exchanging environment. There is a lack of robust evidence for the routine use of surfactant therapy during initial resuscitation of infants with CDH and thus administration cannot be recommended outside clinical trials. Additionally, inhaled nitric oxide has been shown to have no benefit in reducing the mortality rates of infants with CDH. Other therapeutic agents which beneficially act on pulmonary hypertension are currently being assessed in infants with CDH in randomised multicentre trials. The role of novel ventilatory modalities such as closed loop automated oxygen control, liquid ventilation and heliox therapy may offer promise for infants with CDH, but the benefits need to be determined in appropriately designed clinical trials.https://www.frontiersin.org/articles/10.3389/fped.2021.808317/fullmechanical ventilationpressure controlled ventilationvolume controlled ventilationhigh frequency oscillationsurfactantinhaled nitric oxide
spellingShingle Emma Williams
Anne Greenough
Anne Greenough
Anne Greenough
Respiratory Support of Infants With Congenital Diaphragmatic Hernia
Frontiers in Pediatrics
mechanical ventilation
pressure controlled ventilation
volume controlled ventilation
high frequency oscillation
surfactant
inhaled nitric oxide
title Respiratory Support of Infants With Congenital Diaphragmatic Hernia
title_full Respiratory Support of Infants With Congenital Diaphragmatic Hernia
title_fullStr Respiratory Support of Infants With Congenital Diaphragmatic Hernia
title_full_unstemmed Respiratory Support of Infants With Congenital Diaphragmatic Hernia
title_short Respiratory Support of Infants With Congenital Diaphragmatic Hernia
title_sort respiratory support of infants with congenital diaphragmatic hernia
topic mechanical ventilation
pressure controlled ventilation
volume controlled ventilation
high frequency oscillation
surfactant
inhaled nitric oxide
url https://www.frontiersin.org/articles/10.3389/fped.2021.808317/full
work_keys_str_mv AT emmawilliams respiratorysupportofinfantswithcongenitaldiaphragmatichernia
AT annegreenough respiratorysupportofinfantswithcongenitaldiaphragmatichernia
AT annegreenough respiratorysupportofinfantswithcongenitaldiaphragmatichernia
AT annegreenough respiratorysupportofinfantswithcongenitaldiaphragmatichernia